Bioflavonoids, type II [3H]estradiol binding sites and prostatic cancer cell proliferation

International Journal of Oncology

Volumn 11, Issue 6, 1997, Pages 1311-1319

  Markaverich, Barry M ^a   Alejandro, Mary A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

LNCaP; Luteolin; PC 3 cells; Type II sites

Indexed keywords

BIOFLAVONOID; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; LUTEOLIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE PHASE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BINDING SITE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; TUMOR XENOGRAFT;

EID: 0030730095     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Eriksson H, Upchurch S, Hardin JW, Peck EJ Jr and Clark JH: Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of the rat uterus. Biochem Biophys Res Commun 81: 1-7, 1978.
2. Markaverich BM and Clark JH: Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response. Endocrinology 105: 1458-1462, 1979.
3. Markaverich BM, Upchurch S and Clark JH: Progesterone and dexamethasone antagonism of uterine growth: a role for a second nuclear estrogen binding site for estradiol in estrogen action. J Steroid Biochem 14: 125-132, 1981.
4. 3H]estradiol binding in rat uterine nuclei. J Biol Chem 258: 11663-11671, 1983.
5. 3H]estradiol binding in normal and malignant tissues. Cancer Res 44: 1515-1519, 1984.